Get started
Author

A. Lavrinova

Observed names: A. O. Lavrinova, A.O. Lavrinova, Anna Lavrinova, Anna O. Lavrinova, А. О. Лавринова, А.О. Лавринова, Лавринова А. О.
ORCID: 0009-0007-2824-5762
Observed ORCID: 0009-0007-2824-5762
OpenAlex ID: A5072126429
Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson’s disease
2016 · S. Pchelina, A. Emelyanov, et al. · Neuroscience Letters · 82
Increased α‐Synuclein Level in CD45 + Blood Cells in Asymptomatic Carriers of GBA Mutations
2021 · Anton Emelyanov, Tatiana Usenko, et al. · Movement Disorders · 12
Blood Glucocerebrosidase Activity and α-Synuclein Levels in Patients with GBA1-Associated Parkinson's Disease and Asymptomatic GBA1 Mutation Carriers
2024 · Anton K. Emelyanov, Tatiana S. Usenko, et al. · Annals of Clinical and Experimental Neurology · 4
PDF
The Effect of Dopamine on Gene Expression of Alpha-synuclein and Transcription Factors GATA-1, GATA-2, and ZSCAN21 in Parkinson’s Disease
2018 · A. K. Emelyanov, A. O. Lavrinova, et al. · Cell and Tissue Biology · 3
SNCA Variants and Expression Levels of α-synuclein Transcripts in Multiple System Atrophy: A Retrospective Case–control Study
2026 · Alexandr Zhuravlev, Anna Lavrinova, et al. · Gene Expression · 2
PDF
Decreased DNA methyltransferase 1 level in blood cells in Parkinson’s disease
2025 · A.O. Lavrinova, E.M. Litusova, et al. · Neuroscience · 2
mTOR Inhibition Drives Mutation-Specific Remodeling of Lysosomal and Autophagic Pathways and GCase Activity in PBMC-Derived Macrophages from Patients with GBA1-Associated Parkinson’s Disease
2026 · Anastasia Bezrukova, Katerina Basharova, et al. · Current Issues in Molecular Biology · 1
PDF
LRRK2 Inhibition Differently Affects Lysosomal Hydrolase Activity and Autophagy-Related Protein Levels in PBMC-Derived Macrophages from Patients with Different Synucleinopathies
2026 · Katerina Basharova, Anastasia Bezrukova, et al. · Biocell · 1
PDF
Investigation of alpha-synuclein in patients with late-onset schizophrenia
2022 · E. Palchikova, M. Nikolaev, et al. · European Psychiatry · 1
PDF
P.0747 The CD45+ blood cells alpha-synuclein concentration in synucleinopathies
2021 · A. Zhuravlev, A. Lavrinova, et al. · European Neuropsychopharmacology · 1
Epigenetic regulation of SNCA gene expression in Parkinson’s disease
2020 · А.К. Емельянов, А.О. Лавринова, et al. · Nauchno-prakticheskii zhurnal «Medicinskaia genetika» · 1
A Novel Glucocerebrosidase Allosteric Activator Prevents MPTP-Induced Neurodegeneration in Mice
2026 · Anton Emelyanov, Alena Kopytova, et al. · International Journal of Molecular Sciences
DNA Methylation of the SNCA Intron 1 and Alpha-Synuclein Expression in the CD45+ Blood Cells in Parkinson’s Disease
2026 · Anna O. Lavrinova, Ekaterina M. Litusova, et al. · Biochemistry (Moscow)
a-синуклеин и активность лизосомных ферментов при синуклеинопатиях
2026 · Емельянов А. К., Усенко Т. С., et al. · cyberleninka.ru
Screening for mutations in the GBA1 and LRRK2 genes in schizophrenia in the Northwestern region of Russia
2026 · Olesya V. Syryeva, Anna O. Lavrinova, et al. · Personalized Psychiatry and Neurology
PDF
The Double Toxic MPTP+CBE Presymptomatic Parkinson-Like Phenotype in Mice
2025 · Sofya N. Pchelina, Anastasia I. Bezrukova, et al. · Biochemistry (Moscow)
Mutations in the genes of lysosomal storage diseases as a risk factor for the development of Parkinson’s disease
2025 · A. K. Emelianov, M. V. Beletskaya, et al. · The Scientific Notes of the Pavlov University
PDF
Уровень альфа-синуклеина в эритроцитах периферической крови при синуклеинопатиях
2024 · А. С. Журавлев, Л. А. Мультатули, et al. · Biotekhnologiya
Ассоциация генетических вариантов гена GBA с риском развития мультисистемной атрофии в северо-западном регионе России
2024 · А. О. Лавринова, А. С. Журавлев, et al. · Biotekhnologiya
P.0881 Screening of CLN3 variants (rs146610181 and rs77595156) in patients with Parkinson's disease in Russia
2021 · H. Fayud, V. Ryzhkova, et al. · European Neuropsychopharmacology
Dopamine Effect on the Snca and Gata-1 , Gata-2 , Zscan21 Genes Expression in Parkinson’s Disease
2018 · A. K. Emelyanov, A. O. Lavrinova, et al. · Tsitologiya
Plasma Dopamine and Snca Gene Expression in Cd45 + Peripheral Blood Cells in Parkinson’s Desease
2018 · A. K. Emelyanov, A. O. Lavrinova, et al. · Tsitologiya
Dopamine decreases SNCA gene expression in peripheral blood lymphocytes from Parkinson’s disease patients in vitro
2017 · A. Lavrinova, E. Litusova, et al. · European Neuropsychopharmacology
Dopamine decreases SNCA gene expression in peripheral blood lymphocytes from Parkinson's disease patients in vitro
2017 · Anna Lavrinova
a-синуклеин и активность лизосомных ферментов при синуклеинопатиях
· Емельянов А. К., Усенко Т. С., et al. · CyberLeninK (CyberLeninka)
Works count: 25
Citation count: 110
H-index: 3
I10-index: 2
Year
Topic
Type